BEMPEG
Showing 1 - 8 of 8
Covid-19, Coronavirus Disease 2019 Trial in Hialeah, Winter Park, Mesquite (Bempegaldesleukin, Standard of Care, Placebo)
Completed
- Covid-19
- Coronavirus Disease 2019
- Bempegaldesleukin
- +2 more
-
Hialeah, Florida
- +3 more
Mar 31, 2022
Ependymoma, Ewing Sarcoma, High-grade Glioma Trial in Worldwide (Nivolumab, NKTR-214)
Completed
- Ependymoma
- +9 more
- Nivolumab
- NKTR-214
-
Little Rock, Arkansas
- +17 more
Dec 8, 2022
Metastatic Head Neck Cancer, Recurrent Head Neck Cancer Trial in Worldwide (Bempegaldesleukin, Pembrolizumab)
Terminated
- Metastatic Head and Neck Cancer
- Recurrent Head and Neck Cancer
-
Omaha, Nebraska
- +3 more
Dec 16, 2022
Renal Cell Carcinoma Trial in Worldwide (Nivolumab, Bempegaldesleukin, Axitinib)
Active, not recruiting
- Renal Cell Carcinoma
- Nivolumab
- +2 more
-
Springdale, Arkansas
- +33 more
Nov 22, 2022
Bladder Cancer, Bladder Tumor, Muscle-Invasive Bladder Cancer Trial in Worldwide (Nivolumab, Bempegaldesleukin, Radical
Active, not recruiting
- Bladder Cancer
- +2 more
- Nivolumab
- +2 more
-
Gilbert, Arizona
- +115 more
Jan 9, 2023
Renal Cell Carcinoma, Metastatic Renal Cell Carcinoma Trial in Worldwide (bempegaldesleukin, sunitinib, nivolumab)
Active, not recruiting
- Renal Cell Carcinoma
- Metastatic Renal Cell Carcinoma
- bempegaldesleukin
- +3 more
-
Anchorage, Alaska
- +108 more
Mar 31, 2022
Urinary Bladder Tumor, Tumor Metastasis Trial in Worldwide (Bempegaldesleukin, Nivolumab)
Completed
- Urinary Bladder Neoplasm
- Neoplasm Metastasis
- Bempegaldesleukin
- Nivolumab
-
San Francisco, California
- +69 more
Jul 22, 2022